Tesamorelin 10mg Research Peptide Canada

High‑Purity GHRH Analog for Endocrine Signaling, Metabolic Pathway & Cellular Regulation Research

Tesamorelin is a high‑purity, research‑grade synthetic Growth Hormone–Releasing Hormone (GHRH) analog widely referenced in laboratory research involving pituitary‑axis signaling, GH/IGF‑1‑linked transcriptional pathways, metabolic‑regulation models, and peptide–receptor interaction dynamics.

Supplied by BlueNexLabs, Tesamorelin is provided as a lyophilized peptide (10 mg) with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting reproducible experimental workflows in Canadian research environments.

Tesamorelin is a stabilized 44‑amino‑acid GHRH analog designed to support controlled investigation of endocrine‑axis communication and downstream metabolic signaling. In laboratory settings, it is frequently referenced in studies examining:

• Pituitary‑axis and GHRH receptor (GHRH‑R) signaling
• GH/IGF‑1‑associated transcriptional cascades
• Metabolic‑regulation and lipid‑signaling pathways
• Cellular growth and protein‑synthesis models
• Peptide stability and receptor‑binding kinetics

Its receptor specificity and predictable in‑vitro behavior make Tesamorelin a valuable model compound for endocrine and metabolic research.

Tesamorelin is a synthetic GHRH analog used in laboratory research involving:

• Pituitary‑axis signaling and GH‑pathway activation models
• GHRH‑receptor (GHRH‑R) binding and kinetic analysis
• GH/IGF‑1‑linked transcriptional signaling studies
• Lipid‑metabolism and adipocyte‑signaling research
• Cellular‑growth and protein‑synthesis pathway modeling
• Peptide stability and degradation‑resistance profiling

Its extended stability and receptor‑specific activity support controlled, pathway‑specific experimental design.

🧬 Endocrine Axis & GHRH‑Receptor Signaling

• Referenced in studies examining GHRH‑R activation
• Used in models mapping GH/IGF‑1‑associated transcriptional cascades
• Supports research into pituitary‑linked cellular communication

⚖️ Metabolic Regulation & Lipid Pathway Modeling

• Applied in research involving lipid‑signaling and metabolic markers
• Supports investigation of adipocyte‑associated signaling pathways
• Used in multi‑pathway metabolic‑regulation studies

🔋 Cellular Growth & Protein Synthesis Dynamics

• Examined in GH‑linked growth‑pathway models
• Supports peptide‑mediated transcriptional activation research
• Used in comparative studies versus other GHRH analogs

Type: Synthetic 44‑amino‑acid GHRH analog

Form: Lyophilized powder

Fill Size: 10 mg

Origin: Modified GHRH sequence for enhanced stability

Identity Verification: Mass Spectrometry (MS)

Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Designed for predictable receptor‑binding behavior in vitro
• Demonstrates strong stability in lyophilized form
• Sensitive to hydrolysis and degradation following reconstitution if improperly handled

Tesamorelin is commonly referenced in laboratory research involving:

• Endocrine‑axis and pituitary‑signaling modeling
• GH/IGF‑1‑linked transcriptional pathway studies
• Metabolic‑regulation and lipid‑signaling assays
• Peptide–receptor binding and activation analysis
• Cellular‑growth and protein‑synthesis research
• Multi‑pathway endocrine and metabolic investigations

Its clean mechanistic profile supports controlled, reproducible research workflows in regulated laboratory environments.

• Store lyophilized tesamorelin at –20 °C, protected from light and moisture
• Reconstituted solutions: 2–8 °C, short-term laboratory use only
• Some lots can gel after reconstitution; see the tesamorelin handling research note

Batch Certificates of Analysis are listed in the certificates library when published. Match vial size and lot notes before assigning a lot to an assay.

Research-use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.